Synapse - Oncology Research and Treatment

Oncology Research and Treatment

Published by: S. Karger AG

People

Yaeger

Groups

Search Within

Results (1)

BEACON CRC: A randomized, phase 3 study of encorafenib (ENCO) and cetuximab (CETUX) with or without binimetinib (BiNI) vs. choice of either irinotecan or folfiri plus cetux in BRAF V600E-mutant metastatic colorectal cancer (mCRC)

Meeting Abstract

Vogel, A.; Hegewisch-Becker, S.; Prager, G.; Folprecht, G.; Stahl, M.; Kopetz, S.; Grothey, A.; van Cutsetn, E.; Yaeger, R.; Wasan, H.; more...
Oncology Research and Treatment (2020)

Fulltext@MSK | Save

Oncology Research and Treatment – authorized name for:

Name	ISSN / ISBN	Publisher
Oncology Research and Treatment	22965270	Unknown
Oncology Research and Treatment	2296-5270	Karger
Oncology research and treatment	22965262	Unknown
Oncology Research and Treatment	2296-5270	S. Karger AG
Oncology Research and Treatment	2296-5270	S. Karger AG